SGMT
SGMT
NASDAQ · Biotechnology

Sagimet Biosciences Inc-A

Stocks Under $10 Biotech Stocks Healthcare Stocks
$5.55
+0.11 (+2.02%)
As of Feb 8, 2:06 PM ET ·
Analyst Consensus
Strong Buy
16
Analysts
High
Coverage
Buy 15 94%
Hold 1 6%
Sell 0 0%
Price Target
Analyst Price Target -45.9% upside
Low Target $2.20
Average Target $3.00
High Target $3.42
Current Price $5.55
Current
$5.55
Target
$3.00
$2.20 $3.00 avg $3.42
Scenario Analysis
Bear Case
$2.20
-60.4%
Low target
Base Case
$3.00
-45.9%
Avg target
Bull Case
$3.42
+-38.4%
High target
Risk/Reward
0.6x
Unfavorable
Price in Context
52-Week High
$3.51
58.1% from high
52-Week Low
$1.90
+192.1% from low
Target vs 52W High
$3.00
-14.5% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Buy 37 68% $257.58 +15.3%
AMGN
Amgen Inc
 Hold 41 54% $190.87 -50.3%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +137.8%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 77% $438.34 -8.3%
REGN
Regeneron Pharmaceuticals
 Strong Buy 36 75% $76.80 -90.2%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -68.8%
INSM
Insmed Inc
 Strong Buy 27 93% $143.40 -4.3%
BIIB
Biogen Inc
 Hold 42 48% $91.45 -54.5%